Recipharm AB: Interim Report January - September 2015

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

July - September 2015

· Net sales amounted to SEK 785 million (508), an increase of 55%

· EBITDA increased by 68% and amounted to SEK 86 million (51) giving an EBITDA margin of 11.0% (10.1)

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC